Zevra announces board of directors and leadership changes

Celebration, fla., may 08, 2023 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (“zevra” or the “company” and formerly kempharm, inc.), a rare disease therapeutics company, today announced changes to the company's board of directors (“board”) and leadership. at the company's recent 2023 annual meeting of stockholders (“annual meeting”), zevra shareholders elected john b. bode, douglas w. calder and corey watton to zevra's board. additionally, as previously announced, wendy l. dixon, ph.d., joined the zevra board on the date of the annual meeting. after the annual meeting, zevra's newly configured board met and unanimously approved the following changes:
ZVRA Ratings Summary
ZVRA Quant Ranking